New imaging agent could sharpen brain tumor detection
NCT ID NCT06474533
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a radioactive tracer called FET that lights up brain tumor cells on a PET scan. Researchers want to see if FET can better detect whether a brain tumor has come back after treatment, and help tell high-grade from low-grade tumors. About 199 people with known or suspected brain tumors will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACRANIAL NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Robot-Assisted brain biopsy study ends early – only 4 patients enrolled
- New proton beam approach may offer hope for aggressive brain tumors
- Brain tumor chemo delivered by pump shows promise in tiny safety trial
- Breast cancer drug could help fight brain tumors
- New combo aims to tackle aggressive brain tumors that have come back
- New scan could reveal brain tumor aggression without surgery